Vifor Pharma AG
F:G2AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vifor Pharma AG
F:G2AB
|
CH |
|
C
|
Canadian Solar Inc
XMUN:L5A
|
CA |
|
Y
|
Yorkville Acquisition Corp
NASDAQ:YORK
|
US |
|
G
|
G8 Education Ltd
SWB:3EAG
|
AU |
|
T
|
Tabcorp Holdings Ltd
DUS:THL
|
AU |
|
R
|
Redcare Pharmacy NV
DUS:RDC
|
NL |
Wall St Price Targets
G2AB Price Targets Summary
Vifor Pharma AG
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G2AB's stock price target?
Not Available
G2AB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Vifor Pharma AG?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Revenue has been -8%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vifor Pharma AG?
Projected CAGR
16%
Over the last 8 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Vifor Pharma AG?
Projected CAGR
31%
Over the last 8 years, the compound annual growth rate for Net Income has been -9%. The projected CAGR for the next 3 years is 31%.
